141 related articles for article (PubMed ID: 10568859)
21. Prevention of tolerance to the antinociceptive effects of systemic morphine by a selective cholecystokinin-B receptor antagonist in a rat model of peripheral neuropathy.
Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
J Pharmacol Exp Ther; 1997 Sep; 282(3):1366-72. PubMed ID: 9316848
[TBL] [Abstract][Full Text] [Related]
22. Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats.
Stoller DC; Sim-Selley LJ; Smith FL
Brain Res; 2007 Apr; 1142():28-36. PubMed ID: 17300766
[TBL] [Abstract][Full Text] [Related]
23. Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy.
Kayser V; Lee SH; Guilbaud G
Neuroscience; 1995 Jan; 64(2):537-45. PubMed ID: 7700537
[TBL] [Abstract][Full Text] [Related]
24. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
[TBL] [Abstract][Full Text] [Related]
25. Receptor-selective antagonism of opioid antinociception in female versus male rats.
Craft RM; Tseng AH; McNiel DM; Furness MS; Rice KC
Behav Pharmacol; 2001 Dec; 12(8):591-602. PubMed ID: 11856896
[TBL] [Abstract][Full Text] [Related]
26. Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
Binder W; Machelska H; Mousa S; Schmitt T; Rivière PJ; Junien JL; Stein C; Schäfer M
Anesthesiology; 2001 Jun; 94(6):1034-44. PubMed ID: 11465595
[TBL] [Abstract][Full Text] [Related]
27. Involvement of substance P in the anti-inflammatory effects of the peripherally selective kappa-opioid asimadoline and the NK1 antagonist GR205171.
Binder W; Scott C; Walker JS
Eur J Neurosci; 1999 Jun; 11(6):2065-72. PubMed ID: 10336675
[TBL] [Abstract][Full Text] [Related]
28. Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain.
Desmeules JA; Kayser V; Guilbaud G
Pain; 1993 Jun; 53(3):277-285. PubMed ID: 8394563
[TBL] [Abstract][Full Text] [Related]
29. Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test.
Chen X; Geller EB; Adler MW
Eur J Pharmacol; 2007 Feb; 557(1):32-6. PubMed ID: 17173891
[TBL] [Abstract][Full Text] [Related]
30. The kappa opioid receptor agonist SA14867 has antinociceptive and weak sedative effects in models of acute and chronic pain.
Tsukahara-Ohsumi Y; Tsuji F; Niwa M; Hata T; Narita M; Suzuki T; Sasano M; Aono H
Eur J Pharmacol; 2011 Dec; 671(1-3):53-60. PubMed ID: 21970808
[TBL] [Abstract][Full Text] [Related]
31. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
[TBL] [Abstract][Full Text] [Related]
32. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
33. Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic Pain.
Tzschentke TM; Linz K; Frosch S; Christoph T
Pain Pract; 2017 Nov; 17(8):1032-1041. PubMed ID: 28112482
[TBL] [Abstract][Full Text] [Related]
34. Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat.
Caram-Salas NL; Reyes-García G; Bartoszyk GD; Araiza-Saldaña CI; Ambriz-Tututi M; Rocha-González HI; Arreola-Espino R; Cruz SL; Granados-Soto V
Eur J Pharmacol; 2007 Nov; 573(1-3):75-83. PubMed ID: 17643411
[TBL] [Abstract][Full Text] [Related]
35. The development of pain-related behaviour and opioid tolerance after neuropathy-inducing surgery and sham surgery.
Christensen D; Kayser V
Pain; 2000 Dec; 88(3):231-238. PubMed ID: 11068110
[TBL] [Abstract][Full Text] [Related]
36. Antiallodynic Effects of Endomorphin-1 and Endomorphin-2 in the Spared Nerve Injury Model of Neuropathic Pain in Mice.
Wang CL; Yang DJ; Yuan BY; Qiu TT
Anesth Analg; 2017 Dec; 125(6):2123-2133. PubMed ID: 28787346
[TBL] [Abstract][Full Text] [Related]
37. GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity.
Rogers H; Birch PJ; Harrison SM; Palmer E; Manchee GR; Judd DB; Naylor A; Scopes DI; Hayes AG
Br J Pharmacol; 1992 Aug; 106(4):783-9. PubMed ID: 1327387
[TBL] [Abstract][Full Text] [Related]
38. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
Lilius TO; Rauhala PV; Kambur O; Rossi SM; Väänänen AJ; Kalso EA
Anesth Analg; 2012 Jun; 114(6):1353-8. PubMed ID: 22556211
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of selective NK(1) receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain.
Gonzalez MI; Field MJ; Hughes J; Singh L
J Pharmacol Exp Ther; 2000 Aug; 294(2):444-50. PubMed ID: 10900217
[TBL] [Abstract][Full Text] [Related]
40. Concurrent bullatine A enhances morphine antinociception and inhibits morphine antinociceptive tolerance by indirect activation of spinal κ-opioid receptors.
Huang Q; Sun ML; Chen Y; Li XY; Wang YX
J Ethnopharmacol; 2017 Jan; 196():151-159. PubMed ID: 27989510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
